Literature DB >> 7831667

Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. The PLAT Group.

M Cortellaro1, E Cofrancesco, C Boschetti, L Mussoni, M B Donati, M Catalano, L Gabrielli, B Lombardi, G Specchia, L Tavazzi.   

Abstract

Patients with peripheral arterial disease have a high risk of death from cardiovascular events. As defective fibrinolysis associated with leg atherosclerosis has been suggested as a predisposing factor, we sought a relation among decreased fibrinolysis, the presence of leg atherosclerosis and the incidence of thrombotic events in a case-control study nested in the PLAT. Fifty-eight patients with coronary and/or cerebral atherothrombotic disease, free of leg atherosclerosis at Doppler examination, were compared with 50 atherosclerotic patients with leg involvement. High D-dimer (153.0 vs 81.3 ng/ml, p < 0.001) and tPA antigen before venous stasis (14.4 vs 11.8 ng/ml, p < 0.03), and low tPA antigen (6.7 vs 15.6 ng/ml, p < 0.01) and fibrinolytic activity released after venous stasis (fibrinolytic capacity: 113.2 vs 281.4 mm2, p < 0.001) were found in patients with leg atherosclerosis. D-dimer and fibrinolytic capacity, in addition to age, were selected by stepwise discriminant analysis as characterizing patients with leg atherosclerosis. Moreover, higher D-dimer and tPA inhibitor characterized patients with leg atherosclerosis who subsequently experienced thrombotic events. These findings constitute evidence of high fibrin turnover and impaired fibrinolytic potential in patients with leg atherosclerosis. Thus impaired fibrinolysis may contribute to the prothrombotic state in these patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7831667

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

Review 1.  Antithrombotic treatment for peripheral arterial disease.

Authors:  Daniel G Hackam; John W Eikelboom
Journal:  Heart       Date:  2006-10-11       Impact factor: 5.994

2.  Plasma Markers of Procoagulant Activity Among Individuals with Coronary Artery Disease.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

3.  Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case-Control Study.

Authors:  Marie-Claire F Kleinegris; Joke Konings; Jan W Daemen; Yvonne Henskens; Bas de Laat; Henri M H Spronk; Arina J Ten Cate-Hoek; Hugo Ten Cate
Journal:  Front Cardiovasc Med       Date:  2017-04-20

4.  The Clinical Utility of D-Dimer and Prothrombin Fragment (F1+2) for Peripheral Artery Disease: A Prospective Study.

Authors:  Sara Arfan; Abdelrahman Zamzam; Muzammil H Syed; Shubha Jain; Niousha Jahanpour; Rawand Abdin; Mohammad Qadura
Journal:  Biomedicines       Date:  2022-04-11

5.  Escalation of Antithrombotic Therapy Should Be Considered in the Presence of Intraluminal Prosthetic Graft Thrombus Following Endovascular Aneurysm Repair.

Authors:  Terri-Ann Russell; Sivaram Premnath; Meera Mogan; Grace Langford; Bronte Paice; James Kirk; Timothy Rowlands; Ganesh Kuhan
Journal:  EJVES Vasc Forum       Date:  2022-03-16

6.  Blood coagulation and the risk of atherothrombosis: a complex relationship.

Authors:  Henri Mh Spronk; Danielle van der Voort; Hugo Ten Cate
Journal:  Thromb J       Date:  2004-12-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.